PPT-The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
Author : ishaan | Published Date : 2024-09-09
John McMurray BHF Cardiovascular Research Centre University of Glasgow amp Queen Elizabeth University Hospital Glasgow UK On behalf of the DAPAHF Committees and
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "The Dapagliflozin and Prevention of Adve..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF): Transcript
John McMurray BHF Cardiovascular Research Centre University of Glasgow amp Queen Elizabeth University Hospital Glasgow UK On behalf of the DAPAHF Committees and Investigators Results in Nondiabetic Patients. Gender differences and similarities. Lynette W. . Lissin. , MD FACC. Palo Alto Medical Foundation. April 21, 2012. Goals. Epidemiology and types of heart failure. Differences in incidence, clinical characteristics, prognosis in women vs. men. Michelle A. Hart MD CCFP . M.Sc.C.H. . Sid Feldman MD CCFP FCFP. Baycrest Health Sciences, Toronto, ON. Department of Family and Community Medicine,. University of Toronto. Faculty/Presenter Disclosure. Are You Prepared?. Lois . Ustanko. , RN, MHA. Director of Health Ministries, Sanford Health Fargo. Victoria Teske, MS GNP-BC. Assistant Professor. Minnesota State University Moorhead. Nurse Practitioner Long Term Care. (2013 Updated Guidelines). Blake Wachter, MD, PhD. Idaho Heart Institute. Heart Failure: Significant Clinical and Economic Burden. Persons with HF in the . US. . 5.1 million. 20% of Americans > 40yrs. or Focus in this image?. Main Subject or Focus:. . I believe the main subject of this image is the circular flow chart. The arm and hand are placed on the side of the image where they aren’t noticed until you have read all the words, . for the DECLARE – TIMI 58 Investigators. American Heart Association, Scientific Sessions. November 10, 2018. Embargoed Until Saturday Nov. 10, 3:45 pm CT, 4:45 pm ET . Background. Patients with type 2 DM are at high risk for . to request DA P A . Want to learn more? www.uscis.gov/immigrationaction . WHO CAN REQUEST DA P A? You may be considered for DAPA if you: Have lived in the United States continuously since Jan. N ATIONAL I L AW C ENTER | WWW . NILC . ORG L OS A NGELES (Headquarters) 3435 Wilshire Blvd., Suite 2850 Los Angeles, CA 90010 213 639 - 3900 213 639 - 3911 fax W ASHINGTON , DC 1 121 14 th Street RIMENDOR PROGRAMPA OVERVIEWThisigned to simplifocesanufacturer/supplieestablishDistributiond PriciAgreemenDAPA Establishing isa manufacturer146sansupplier146keyccessfularticipationinDefenseLogisicsAge Table of ContentsUnderstanding Heart FailureWhat is Congestive Heart Failure (CHF)?with Heart FailureHeart Failure ZonesHeart Failure medicationsLearning to read food labelsDaily life with Heart Failu of symptoms . and signs of heart failure secondary to . abnormal cardiac . function, causing elevated cardiac filling pressures.. This causes severe . dyspnoea. and fluid accumulates in . the . interstition. Heart pumps more than 7500 L of blood through the body each day, and beating more than 40 million times a year. Weight of the heart – 0.4% - 0.5% of body weight (250-320g in females and 300 – 360g in males). neonates. Dr. . Sanmath. Shetty K. Senior Resident, . Dept. of Cardiology. Medical College, Calicut. Definition of Heart Failure. Brief review . of . Pathophysiology. Unique features of heart failure in neonates.. . . failure of the heart to pump blood adequately. Cardiac failure is manifested by two ways---. 1) . C.O.. 2) . C.O.. . . .
Download Document
Here is the link to download the presentation.
"The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents